Fusion Genomics Corporation

Fusion Genomics is a Vancouver-based biotechnology company that is pushing the frontiers of molecular diagnostics with proprietary technologies, combined with Next Generation Sequencing, to create genomic testing for pathogens. Fusion Genomics is seeking to tackle the global problem of idiopathic infections, which cost the global economy billions of dollars in hospitalizations and lost productivity and exact a heavy human toll in hundreds of lost lives. Fusion Genomics disruptive DNA and RNA capture technology, part of a benchtop to desktop solution called the ONETestTM platform enables the comprehensive identification of pathogens from virtually any source, including blood, sputum, stool, swabs, and...

Molecular diagnostics,gene fusions,next generation sequencing,cloud analytics,bioinformatics,onetestᵀᴹ,quantumprobesᵀᴹ,fusioncloudᵀᴹ,uniprepᵀᴹ,dna and rna capture,infectious diseases,and product development

Fusion genomics corporation operates in the Biotechnology research industry.

Fusion genomics corporation's revenue is 11m - 100m

Fusion genomics corporation has 11 - 50 employees.